Testing effectiveness (Phase 2)Study completedNCT00010387
What this trial is testing
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Who this might be right for
Anemia, Hemolytic, AutoimmuneFelty SyndromePurpura, Thrombocytopenic+1 more
Johns Hopkins University 32